Quanta Therapeutics Presents Late-Breaking Data for QTX3034, a multi-KRAS inhibitor, at AACR-NCI-EORTC Conference by Seini Moimoi | Oct 11, 2023 | Portfolio News
CuraSen Therapeutics Announces Strategic Investment from the Alzheimer’s Drug Discovery Foundation to Advance CST-3056, an Alpha-1A Adrenoceptor Agonist, for the Treatment of Alzheimer’s Disease by Seini Moimoi | Oct 9, 2023 | Portfolio News
Mirum Pharmaceuticals Announces Positive Phase 3 RESTORE Study Results Evaluating Chenodal in Patients with Cerebrotendinous Xanthomatosis by Seini Moimoi | Oct 2, 2023 | Portfolio News
Avenge Bio Receives FDA Fast Track Designation for AVB-001, a Novel Cell Therapy Leveraging the LOCOcyte™ Immunotherapy Platform by Seini Moimoi | Oct 2, 2023 | Portfolio News
Inozyme Pharma Announces Positive Interim Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) by Seini Moimoi | Sep 26, 2023 | Portfolio News
Patients Receiving Somatus Transitions of Care Assessment Services 49% Less Likely to Experience Hospital Readmission by Seini Moimoi | Sep 26, 2023 | Portfolio News
